WHO SPECIFICATIONS AND EVALUATIONS

FOR PUBLIC HEALTH PESTICIDES

FENITROTHION

O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate

 TABLE OF CONTENTS

Page

DISCLAIMER 3

INTRODUCTION 4

PART ONE

SPECIFICATIONS FOR FENITROTHION 5

FENITROTHION INFORMATION 6
FENITROTHION TECHNICAL MATERIAL (JANUARY 2010) 7
FENITROTHION WETTABLE POWDER (JANUARY 2010) 9
FENITROTHION EMULSIFIABLE CONCENTRATE
(JANUARY 2010) 12

PART TWO

EVALUATIONS OF FENITROTHION 15

2009 FAO/WHO EVALUATION REPORT ON FENITROTHION 16

SUPPORTING INFORMATION 19
ANNEX 1: HAZARD SUMMARY PROVIDED BY PROPOSER 25
ANNEX 2: REFERENCES 30

Page 2 of 32
 Disclaimer1

WHO specifications are developed with the basic objective of promoting, as far as
practicable, the manufacture, distribution and use of pesticides that meet basic
quality requirements.
Compliance with the specifications does not constitute an endorsement or warranty
of the fitness of a particular pesticide for a particular purpose, including its suitability
for the control of any given pest, or its suitability for use in a particular area. Owing
to the complexity of the problems involved, the suitability of pesticides for a particular
purpose and the content of the labelling instructions must be decided at the national
or provincial level.
Furthermore, pesticides which are manufactured to comply with these specifications
are not exempted from any safety regulation or other legal or administrative provision
applicable to their manufacture, sale, transportation, storage, handling, preparation
and/or use.
WHO disclaims any and all liability for any injury, death, loss, damage or other
prejudice of any kind that may be arise as a result of, or in connection with, the
manufacture, sale, transportation, storage, handling, preparation and/or use of
pesticides which are found, or are claimed, to have been manufactured to comply
with these specifications.
Additionally, WHO wishes to alert users to the fact that improper storage, handling,
preparation and/or use of pesticides can result in either a lowering or complete loss
of safety and/or efficacy.
WHO is not responsible, and does not accept any liability, for the testing of
pesticides for compliance with the specifications, nor for any methods recommended
and/or used for testing compliance. As a result, WHO does not in any way warrant
or represent that any pesticide claimed to comply with a WHO specification actually
does so.
____________________________________

1
This disclaimer applies to all specifications published by WHO.

Page 3 of 32
 INTRODUCTION

WHO establishes and publishes specifications* for technical material and related
formulations of public health pesticides with the objective that these specifications
may be used to provide an international point of reference against which products
can be judged either for regulatory purposes or in commercial dealings.

From 2002, the development of WHO specifications follows the New Procedure,
described in the Manual for Development and Use of FAO and WHO Specifications
for Pesticides. This New Procedure follows a formal and transparent evaluation
process. It describes the minimum data package, the procedure and evaluation
applied by WHO and the experts of the “FAO/WHO Joint Meeting on Pesticide
Specifications” (JMPS).

WHO Specifications now only apply to products for which the technical materials
have been evaluated. Consequently, from the year 2002 onwards the publication of
WHO specifications under the New Procedure has changed. Every specification
consists now of two parts, namely the specifications and the evaluation report(s):

Part One: The Specifications of the technical material and the related formulations of
the pesticide in accordance with chapters 4 to 9 of the “FAO/WHO Manual
on Pesticide Specifications.”

Part Two: The Evaluation Report(s) of the pesticide, reflecting the evaluation of the
data package carried out by WHO and the JMPS. The data are provided
by the manufacturer(s) according to the requirements of chapter 3 of the
“FAO/WHO Manual on Pesticide Specifications” and supported by other
information sources. The Evaluation Report includes the name(s) of the
manufacturer(s) whose technical material has been evaluated. Evaluation
reports on specifications developed subsequently to the original set of
specifications are added in a chronological order to this report.

WHO specifications under the New Procedure do not necessarily apply to nominally
similar products of other manufacturer(s), nor to those where the active ingredient is
produced by other routes of manufacture. WHO has the possibility to extend the
scope of the specifications to similar products but only when the JMPS has been
satisfied that the additional products are equivalent to that which formed the basis of
the reference specification.

Specifications bear the date (month and year) of publication of the current
version. Dates of publication of the earlier versions, if any, are identified in a
footnote. Evaluations bear the date (year) of the meeting at which the
recommendations were made by the JMPS.

* Footnote: The publications are available on the Internet under

(http://www.who.int/whopes/quality/en/).

Page 4 of 32
 PART ONE

SPECIFICATIONS

Page
FENITROTHION

FENITROTHION INFORMATION 6
FENITROTHION TECHNICAL MATERIAL (JANUARY 2010) 7
FENITROTHION WETTABLE POWDER (JANUARY 2010) 9
FENITROTHION EMULSIFIABLE CONCENTRATE
(JANUARY 2010) 12

Page 5 of 32
 WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES

FENITROTHION

INFORMATION
Common name
fenitrothion (BSI, E-ISO, (m) F-ISO, ESA, BAN)
Synonyms
sumithion, MEP
Chemical names
IUPAC: O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
CA: O,O-dimethyl O-(3-methyl-4-nitrophenyl) phosphorothioate
Structural formula
S
CH3O
P O NO2
CH3O
CH3

Molecular formula
C9H12NO5PS
Relative molecular mass
277.25
CAS Registry number
112-14-5
CIPAC number
35
Identity tests
HPLC retention time, IR spectrum.

Page 6 of 32
 WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES

FENITROTHION TECHNICAL MATERIAL

WHO specification 35/TC (January 2010∗)
This specification, which is PART ONE of this publication, is based on an evaluation
of data submitted by the manufacturer whose name is listed in the evaluation report
(35/2009). It should be applicable to TC produced by this manufacturer but it is not
an endorsement of those products, nor a guarantee that they comply with the
specifications. The specification may not be appropriate for TC produced by other
manufacturers. The evaluation report (35/2009), as PART TWO, form an integral
part of this publication.

1 Description
The material shall consist of fenitrothion together with related manufacturing
impurities and, below its decomposition (boiling) point (Note 1), shall be a pale
yellow to yellowish brown oil, faint characteristic odour, free from visible
extraneous matter and added modifying agents.

2 Active ingredient
2.1 Identity tests (CIPAC 35/TC/m3/2) (Notes 2 & 3)
The active ingredient shall comply with an identity test and, where the identity
remains in doubt, shall comply with at least one additional test.
2.2 Fenitrothion content (CIPAC 35/TC/m3/3) (Note 2)
The fenitrothion content shall be declared (not less than 930 g/kg) and, when
determined, the average measured content shall not be lower than the
declared minimum content.

3 Relevant impurities
3.1 S-methyl fenitrothion (CIPAC 35/TC/m3/4) (Note 4)
Maximum: 5 g/kg.
3.2 Tetramethyl pyrophosphorothioate (TMPP) (CIPAC 35/TC/m3/5) (Note 5)
Maximum: 3 g/kg.

Note 1 The melting point should be in the range −1 − +1°C, the decomposition point is around 210°C
(the boiling point cannot be determined). Fenitrothion is always used at temperatures well
below the decomposition point.
Note 2 The normal phase HPLC methods (CIPAC/4602) for the determination of fenitrothion in TC
and in WP, EC and UL formulations were accepted as full CIPAC methods in 2009. Prior to
their publication in Handbook N, copies of the methods may be obtained through the CIPAC
website, http://www.cipac.org/prepubme.htm.

∗
Specifications may be revised and/or additional evaluations may be undertaken.
Ensure the use of current versions by checking at: http://www.who.int/whopes/quality/en/.

Page 7 of 32
Note 3 In addition to HPLC-UV retention times, the infrared spectrum shown in Figure 1 provides
good evidence of the identity of fenitrothion.

Figure 1. Infrared spectrum of fenitrothion.

Note 4 The independent laboratory validated HPLC-UV method (CIPAC/4602) for the determination
of the relevant impurity S-methyl fenitrothion in fenitrothion TC and in WP, EC and UL
formulations was adopted by CIPAC in 2007 and is available through the CIPAC website,
http://www.cipac.org/cipacpub.htm.
Note 5 The independent laboratory validated capillary GC-FID method (CIPAC/4660) for the
determination of the relevant impurity tetramethyl pyrophosphorothioate (TMPP) in
fenitrothion TC and in WP, EC and UL formulations was adopted by CIPAC in 2009 and is
available through the CIPAC website, http://www.cipac.org/cipacpub.htm.

Page 8 of 32
 WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES

FENITROTHION WETTABLE POWDER

WHO specification 35/WP (January 2010∗)
This specification, which is PART ONE of this publication, is based on an evaluation
of data submitted by the manufacturer whose name is listed in the evaluation report
(35/2009). It should be applicable to relevant products of this manufacturer, and
those of any other formulators who use only TC from the evaluated source. The
specification is not an endorsement of those products, nor a guarantee that they
comply with the specification. The specification may not be appropriate for the
products of other manufacturers who use TC from other sources. The evaluation
report (35/2009), as PART TWO, form an integral part of this publication.

1 Description
The material shall consist of a homogeneous mixture of technical fenitrothion,
complying with the requirements of WHO specification 35/TC (January 2010),
together with filler(s) and any other necessary formulants. It shall be in the
form of a fine powder, free from visible extraneous matter and hard lumps.

2 Active ingredient
2.1 Identity tests (CIPAC 35/WP/m3/2) (Notes 1 & 2)
The active ingredient shall comply with an identity test and, where the identity
remains in doubt, shall comply with at least one additional test.
2.2 Fenitrothion content (CIPAC 35/WP/m3/3) (Note 1)
The fenitrothion content shall be declared (g/kg) and, when determined, the
average content measured shall not differ from that declared by more than the
following tolerance.
Declared content in g/kg Tolerance
above 250 up to 500 g/kg ± 5% of the declared content

Note: the upper limit is included in the range.

3 Relevant impurities
3.1 S-methyl fenitrothion (CIPAC 35/WP/m3/4) (Note 3)
Maximum: 2.5% of the fenitrothion content found under clause 2.2.
3.2 Tetramethyl pyrophosphorothioate (TMPP) (CIPAC 35/WP/m3/5) (Note 4)
Maximum: 0.3 % of the fenitrothion content found under clause 2.2.
3.3 Water (MT 30.5, CIPAC Handbook J, p.120, 2000)
Maximum: 30 g/kg.

∗
Specifications may be revised and/or additional evaluations may be undertaken.
Ensure the use of current versions by checking at: http://www.who.int/whopes/quality/en/.

Page 9 of 32
4 Physical properties
4.1 pH range (MT 75.3, CIPAC Handbook J, p.131, 2000)
pH range: 4 to 7.
4.2 Wet sieve test (MT 185, CIPAC Handbook K, p.149, 2003)
Maximum: 2% retained on a 75 µm test sieve.
4.3 Suspensibility (MT 184, CIPAC Handbook K, p.142, 2003) (Notes 5 & 6)
A minimum of 70% of the fenitrothion content found under 2.2 shall be in
suspension after 30 min in CIPAC standard water D at 30 ± 2°C (Note 7).
4.4 Persistent foam (MT 47.2, CIPAC Handbook F, p.152, 1995) (Note 8)
Maximum: 30 ml after 1 min.
4.5 Wettability (MT 53.3, CIPAC Handbook F, p.164, 1995)
The formulation shall be completely wetted in 1 min without swirling.

5 Storage stability
5.1 Stability at elevated temperature (MT 46.3, CIPAC Handbook J, p.128,
2000)
After storage at 54 ± 2°C for 14 days, the determined average active
ingredient content must not be lower than 90%, relative to the determined
average content found before storage (Note 9), and the formulation shall
continue to comply with the clauses for:
- S-methyl fenitrothion (3.1),
- tetramethyl pyrophosphorothioate (TMPP) (3.2),
- pH range (4.1),
- wet sieve test (4.2),
- suspensibility (4.3),
- wettability (4.5),

Note 1 The normal phase HPLC methods (CIPAC/4602) for the determination of fenitrothion in TC
and in WP, EC and UL formulations were accepted as full CIPAC methods in 2009. Prior to
their publication in Handbook N, copies of the methods may be obtained through the CIPAC
website, http://www.cipac.org/prepubme.htm.
Note 2 In addition to HPLC-UV retention times, the infrared spectrum shown in Figure 1, attached to
the specification for fenitrothion TC, provides good evidence of the identity of fenitrothion.
Note 3 The independent laboratory validated HPLC-UV method (CIPAC/4602) for the determination
of the relevant impurity S-methyl fenitrothion in fenitrothion TC and in WP, EC and UL
formulations was adopted by CIPAC in 2007 and is available through the CIPAC website,
http://www.cipac.org/cipacpub.htm.
Note 4 The independent laboratory validated capillary GC-FID method (CIPAC/4660) for the
determination of the relevant impurity tetramethyl pyrophosphorothioate (TMPP) in
fenitrothion TC and in WP, EC and UL formulations was adopted by CIPAC in 2009 and is
available through the CIPAC website, http://www.cipac.org/cipacpub.htm.
Note 5 The formulation should be tested at the highest and lowest rates of use recommended by the
supplier, provided it does not exceed the conditions given in method MT 184.

Page 10 of 32
Note 6 This test will normally only be carried out after the heat stability test 5.1.
Note 7 Chemical assay is the only fully reliable method to measure the mass of active ingredient still
in suspension. However, simpler methods such as gravimetric and solvent extraction
determination may be used on a routine basis provided that these methods have been shown
to give results equal to those of chemical assay. In case of dispute, the chemical method
shall be the "referee method".
Note 8 The mass of sample to be used in the test should be at the highest rate of use recommended
by the supplier. The test is to be conducted in CIPAC standard water D.
Note 9 Samples of the formulation taken before and after the storage stability test should be
analyzed concurrently after the test in order to reduce the analytical error.

Page 11 of 32
 WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES

FENITROTHION EMULSIFIABLE CONCENTRATE

WHO specification 35/EC (January 2010∗)
This specification, which is PART ONE of this publication, is based on an evaluation
of data submitted by the manufacturer whose name is listed in the evaluation report
(35/2009). It should be applicable to relevant products of this manufacturer, and
those of any other formulators who use only TC from the evaluated source. The
specification is not an endorsement of those products, nor a guarantee that they
comply with the specification. The specification may not be appropriate for the
products of other manufacturers who use TC from other sources. The evaluation
report (35/2009), as PART TWO, form an integral part of this publication.

1 Description
The material shall consist of technical fenitrothion, complying with the
requirements of WHO specification 35/TC (January 2010), dissolved in
suitable solvents together with any other necessary formulants. It shall be in
the form of a stable homogeneous liquid, free from visible suspended matter
and sediment, to be applied as an emulsion after dilution in water.

2 Active ingredient
2.1 Identity tests (CIPAC 35/EC/m3/2) (Notes 1 & 2)
The active ingredient shall comply with an identity test and, where the identity
remains in doubt, shall comply with at least one additional test.
2.2 Fenitrothion content (CIPAC 35/EC/m3/3) (Note 1)
The fenitrothion content shall be declared (g/kg or g/l at 20 ± 2°C, Note 3)
and, when determined, the average content measured shall not differ from
that declared by more than the following tolerances.
Declared content in g/kg or g/l at 20 ± 2°C Tolerance
above 250 up to 500 ± 5% of the declared content
above 500 ± 25 g/kg or g/l

Note: the upper limit is included in the range.

3. Relevant impurities
3.1 S-methyl fenitrothion (CIPAC 35/EC/m3/4) (Note 4)
Maximum: 2.5% of the fenitrothion content found under clause 2.2.
3.2 Tetramethyl pyrophosphorothioate (TMPP) (CIPAC 35/WP/m3/5) (Note 5)
Maximum: 0.3 % of the fenitrothion content found under clause 2.2.

∗
Specifications may be revised and/or additional evaluations may be undertaken.
Ensure the use of current versions by checking at: http://www.who.int/whopes/quality/en/.

Page 12 of 32
 3.3 Water (MT 30.5, CIPAC Handbook J, p.120, 2000)
Maximum: 2 g/kg.

4 Physical properties
4.1 pH range (MT 75.3, CIPAC Handbook J, p.131, 2000)
pH range: 3 to 6.
4.2 Emulsion stability and re-emulsification (MT 36.3, CIPAC Handbook K,
p.137, 2003) (Note 6)
The formulation, when diluted at 30 ± 2°C with CIPAC standard waters A and
D, shall comply with the following.
Time after dilution Limits of stability
0h Initial emulsification complete

0.5 h “Cream”, maximum: 0.5 ml

2h “Cream”, maximum: 1 ml
“Free oil”, maximum: 0.5 ml

24 h Re-emulsification complete

24.5 h “Cream”, maximum: 0.5 ml

“Free oil”, maximum: trace
Note: tests after 24 h are required only where
results at 2 h are in doubt.

4.3 Persistent foam (MT 47.2, CIPAC Handbook F, p.152, 1995) (Note 7)
Maximum: 50 ml after 1 min.

5 Storage stability
5.1 Stability at 0°C (MT 39.3, CIPAC Handbook J, p.126, 2000)
After storage at 0 ± 2°C for 7 days, the volume of solid and/or liquid which
separate shall not be more than 0.3 ml.
5.2 Stability at elevated temperature (MT 46.3, CIPAC Handbook J, p.128,
2000)
After storage at 54 ± 2°C for 14 days, the determined average active
ingredient content must not be lower than 95% relative to the determined
average content found before storage (Note 8) and the product shall continue
to comply with the clauses for:
- S-methyl fenitrothion (3.1),
- tetramethyl pyrophosphorothioate (TMPP) (3.2),
- pH range (4.1),
- emulsion stability and re-emulsification (4.2).

Page 13 of 32
Note 1 The normal phase HPLC methods (CIPAC/4602) for the determination of fenitrothion in TC
and in WP, EC and UL formulations were accepted as full CIPAC methods in 2009. Prior to
their publication in Handbook N, copies of the methods may be obtained through the CIPAC
website, http://www.cipac.org/prepubme.htm.
Note 2 In addition to HPLC-UV retention times, the infrared spectrum shown in Figure 1, attached to
the specification for fenitrothion TC, provides good evidence of the identity of fenitrothion.
Note 3 If the buyer requires both g/kg and g/l at 20°C, then in case of dispute the analytical results
shall be calculated as g/kg.
Note 4 The independent laboratory validated HPLC-UV method (CIPAC/4602) for the determination
of the relevant impurity S-methyl fenitrothion in fenitrothion TC and in WP, EC and UL
formulations was adopted by CIPAC in 2007 and is available through the CIPAC website,
http://www.cipac.org/cipacpub.htm.
Note 5 The independent laboratory validated capillary GC-FID method (CIPAC/4660) for the
determination of the relevant impurity tetramethyl pyrophosphorothioate (TMPP) in
fenitrothion TC and in WP, EC and UL formulations was adopted by CIPAC in 2009 and is
available through the CIPAC website, http://www.cipac.org/cipacpub.htm.
Note 6 The test will normally only be carried out after the heat stability test 5.2. Emulsion stability
should be tested with the formulation at 1.0 % concentration.
Note 7 The mass of sample to be used in the test should be at the highest rate of use recommended
by the supplier. The test is to be conducted in CIPAC standard water D.
Note 8 Samples of the formulation taken before and after the storage stability test should be
analyzed concurrently after the test in order to reduce the analytical error.

Page 14 of 32
 PART TWO

EVALUATION REPORTS

FENITROTHION

Page

2009 FAO/WHO evaluation report based on data submitted by

Sumitomo (TC, WP, EC, UL) 16
Supporting Information 19
Annex 1: Hazard summary provided by proposer 25
Annex 2: References 30

Page 15 of 32
 WHO SPECIFICATIONS FOR PUBLIC HEALTH PESTICIDES

FENITROTHION
FAO/WHO EVALUATION REPORT 35/2009

Recommendations
The Meeting recommended the following.
(i) the specifications for fenitrothion TC, WP, EC and UL proposed by Sumitomo
Chemical Co. Ltd., as amended, should be adopted by FAO.
(ii) the specifications for fenitrothion TC, WP and EC proposed by Sumitomo
Chemical Co. Ltd., as amended, should be adopted by WHO.
(iii) the existing FAO specifications for fenitrothion TC, DP, WP, OL, EC (1988) and
UL (1997), and the existing WHO specifications for fenitrothion TC, EC (1999)
and WP (1989), should be withdrawn.

Appraisal
The Meeting considered data and supporting information submitted by Sumitomo
Chemical Co. Ltd. for the review of existing FAO specifications for fenitrothion TC, DP,
WP, OL, EC (1988) and UL (1997), and the existing WHO specifications for fenitrothion
TC, EC (1999) and WP (1989).
Fenitrothion is no longer under patent. Fenitrothion formulated as WP has WHOPES
recommendation for use as indoor residual spraying against malaria vectors.
Fenitrothion was evaluated by the FAO/WHO JMPR and WHO/IPCS several times
(1969, 1974, 1977, 1982, 1983, 1984, 1986, 1988 and 2000) and by WHO/IPCS in
1990. Fenitrothion was also the subject of the “Environmental Health Criteria
Monograph 133” published in 1992. It was evaluated and reviewed by the US EPA
in 1975 and by Japanese Ministry of Health and Welfare in 1975.
The draft specification and the supporting data were provided by the manufacturer
and proposer, Sumitomo Chemical Co., Ltd. in October 2006. The specifications
were updated in March 2007. Concurrently, the published and obsolete CIPAC
method for determination of fenitrothion in TC and formulations based on packed
column GC was replaced by a new fully validated normal phase HPLC method which
was adopted by CIPAC in 2008.
The issue of relevant impurities was discussed by the Meeting. The Meeting
concluded that, based on the criteria in the Specification Manual and available acute
toxicity data, two impurities are considered as relevant in fenitrothion TC and in
formulations: S-methyl fenitrothion and tetramethyl pyrophosphorothioate (TMPP).
For both compounds, peer validated analytical methods for their determination in TC
and formulations are now available.
Fenitrothion is a slightly volatile, non-systemic organophosphorus insecticide of low
water solubility. It is not readily hydrolyzed at slightly acidic and neutral pH (half life
of several months at pH 4 and 7, somewhat faster hydrolysis at pH 9, respectively)
but photolysis is comparatively rapid. It is of short persistence in animals, plants, soil

Page 16 of 32
and water and therefore bioaccumulation is unlikely to occur despite an
octanol/water partition coefficient of 3.3.
The proposed minimum purity of the fenitrothion TC is 930 g/kg, which was accepted
by the Meeting.
Confidential information on the manufacturing process and impurity profile was
provided by the proposer. The impurity data presented by Sumitomo was essentially
the same as those presented by the company to the Australian authorities for the
purposes of registration. The Australian Pesticide and Veterinary Medicine Authority
(APVMA) commented that “the chemistry and quality control data (manufacturing
process, purity and impurities etc.) submitted by Sumitomo in support of the FAO
and WHO specifications for fenitrothion active constituent are similar to those
assessed by the APVMA for approval of the active constituent”.
The content of the relevant impurity, S-methyl fenitrothion (O,S-dimethyl O-4-nitro-m-
tolyl phosphorothioate), was ≤ 1 g/kg in all batches and hence lower than the
proposed manufacturing limit of 5 g/kg. The content of the relevant impurity
tetramethyl pyrophosphorothioate (TMPP) was ≤ 1 g/kg in all batches and hence
lower than the proposed manufacturing limit of 3 g/kg.
Fenitrothion is a phosphorothionate and other compounds of this type are known to
have the potential to undergo internal transesterification in storage to form a
potentially more toxic S-alkyl isomer. S-methyl fenitrothion is not an impurity carried
forward from one of the raw materials, due to the design and steps involved in the
manufacturing process which is used in the production of fenitrothion TC. S-methyl
fenitrothion can increase in concentration during storage of fenitrothion TC or
formulations in the presence of compounds such as anionic surfactants and at
elevated temperatures.
A small increase in S-methyl fenitrothion concentration was found in the formulations
after the accelerated storage test at 54°C for 14 days. As S-methyl fenitrothion can
increase during storage, its concentration must be controlled in all formulations after
the test of stability at elevated temperature. As with other organophosphorous
compounds, fenitrothion shows a somewhat limited stability in the WP formulation,
so the minimum content after the storage test at elevated temperature was set at
90 % which is a deviation from the default 95 % as in the Specification Manual.
Fenitrothion shows a better stability in the EC, where the general limit of 95% is
applicable as compared to the sample before the accelerated stability test.
The methods used to produce the data on the range of physico-chemical properties
and chemical composition are all referenced CIPAC, AOAC and OECD or sufficiently
validated in-house methods.
The JMPS asked the proposer to evaluate the requirement for the inclusion of
clauses for water, as a relevant impurity, and pH as a physical property in the TC
and formulations.
A limit for water was not included in the TC specification for the following reasons:
i) fenitrothion is not prone to hydrolysis by water and,
ii) the isolation procedure of fenitrothion in the last step of the synthesis leads to low
content of water in the TC, which potentially would cause a problem in the
production of oil-based formulations (EC, UL).

Page 17 of 32
However, the limits for water as a relevant impurity in the WP, EC and UL
specifications are required due to the possibility of water being present in the
formulants and possible adverse effect of residual water on physical-chemical
properties of these formulations.
The Meeting concluded that a pH range clause is not required for the TC as well,
due to the sufficient hydrolytic stability of the active ingredient and low water content.
A pH range must be specified for the WP, EC and UL formulations. The rate of
degradation of fenitrothion could be increased by an acidic pH of less than 3 as
quoted in the specifications. Moreover hydrolysis can occur at pH greater than 9 as
shown in the study HM-0094. Fenitrothion, like many other organophosphate
pesticides, is hydrolysed by strong alkali.
The proposed specification for the TC was in accordance with the requirements of
the FAO/WHO Manual. The proposed specifications for the WP, EC and UL were
also in accordance with the requirements of the FAO/WHO Manual.

Page 18 of 32
SUPPORTING INFORMATION
FOR
EVALUATION REPORT 35/2009

Page 19 of 32
Uses
Fenitrothion is an insecticide, acetylcholinesterase inhibitor. It is used in agriculture,
horticulture, forestry and public health against chewing and sucking insects on rice,
cereals, fruits, vegetables, stored grains, cotton, etc., for agriculture and flies,
mosquitoes and cockroaches in public health use.

Identity of the active ingredient

Common name
fenitrothion (BSI, E-ISO, (m) F-ISO, ESA, BAN)
Synonyms
sumithion, MEP
Chemical names
IUPAC: O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
CA: O,O-dimethyl O-(3-methyl-4-nitro-phenyl) phosphorothioate
Structural formula
S
CH3O
P O NO2
CH3O
CH3

Molecular formula
C9H12NO5PS
Relative molecular mass
277.25
CAS Registry number
112-14-5
CIPAC number
35
Identity tests
HPLC retention time, IR spectrum.

Page 20 of 32
Physico-chemical properties of fenitrothion
Table 1. Physico-chemical properties of pure fenitrothion
Parameter Value(s) and conditions Purity % Method reference and
study number
Vapour pressure 1.48 x 10-4 Pa at 10°C 99.1% EPA 830.7950 / OECD 104
6.76 x 10-4 Pa at 20°C / EEC A.4
1.57 x 10-3 Pa at 25°C (interpolated) (HP-0136)
3.39 x 10-3 Pa at 30°C
Melting point, boiling Melting point: -1°C - +1°C 99.2% OECD 102 / EEC A.1
point and/or (HP-0140)
temperature of Boiling point: fenitrothion began to 99.1% OECD 103
decomposition decompose at around 210°C and it (HP-0133)
was impossible to determine the
boiling point.
Decomposition temperature: around
210°C
Solubility in water 19.0 mg/L at 20 ± 0.5 °C 99.1% OECD 105
(in distilled water) (HP-0137)
Octanol/water partition Log Pow = 3.319 ± 0.080 at 25°C 99.3% OECD 107
coefficient (HP-0145)
Hydrolysis Half-life = 100-101 days at 25 ± 1°C >99% EPA 161-1
characteristics at pH 9 (HM-0094)
Half-life = 180-186 days at 25 ± 1°C
at pH 7
Half-life = 191-200 days at 25 ± 1°C
at pH 5
Photolysis Half-life = 3.33-3.65 days at 25 ± 1 >99% EPA 161-2
characteristics °C at pH 5 under light condition (HM-0093)
Half-life = 70.8-140.9 days at 25
±1°C at pH 5 under dark condition
Dissociation Not applicable - -
characteristics (On basis on the structure of the test
material, it is not considered that the
reaction of giving or receiving proton
will occur in water solution
containing fenitrothion)

Page 21 of 32
Table 2. Chemical composition and properties of fenitrothion technical
material (TC)
The chemical composition of the TC, the methods for testing it and the limits
proposed for the TC, comply with the requirements of the FAO/WHO manual (March
2006 revision of the 1st edition). These data are confidential and has been
evaluated, but only the summarised results are presented in the specification
document supplied by Sumitomo.
Manufacturing process, maximum limits for Confidential information supplied and held on file by
impurities ≥1 g/kg, 5 batch analysis data FAO and WHO. Mass balances were 100.4-100.5%.
Percentages of unknowns were 0%
Declared minimum fenitrothion content 930 g/kg
Relevant impurities ≥ 1 g/kg and maximum S-methyl fenitrothion
limits for them (O,S-dimethyl O-4-nitro-m-tolyl phosphorothiolate)
Maximum limit: 5 g/kg
tetramethyl pyrophosphorothioate (TMPP)
Maximum limit: 3 g/kg
Relevant impurities < 1 g/kg and maximum None
limits for them
Stabilizers or other additives and maximum None
limits for them
Melting or boiling temperature range of the TC Boiling point: fenitrothion began to decompose at
around 210°C and it was impossible to determine the
boiling point

Background information on toxicology / ecotoxicology

The data provided by Sumitomo outlined the toxicology (acute, irritation and
sensitization and sub-acute to chronic), mutagenicity and ecotoxicological profile of
the fenitrothion technical material.
Acute toxicity was low in Rats, Rabbits, Guinea Pigs, in both males and females in
general toxicity and neurotoxicity terms, as shown by the LD50, LC50, NOELs and
NOAELs. The Hershberger assay in Rats showed no anti-androgenicity or
androgenicity.
Fenitrothion is unlikely to pose a carcinogenic risk to humans.
Fenitrothion was not genotoxic in a range of studies in vitro and in vivo.
Fenitrothion is not persistent in soil and leaching is not significant. Therefore there is
negligible risk to following crops or of groundwater contamination. Volatilization is a
significant dissipative process in the environment although, once in the vapour
phase, fenitrothion is short-lived. Transport to surface water via spray drift poses a
risk to aquatic species, although the duration of exposure is brief because
fenitrothion dissipates in microbially active natural water systems with a half-life of
less than one week. The compound will also tend to migrate to sediment.
Health risks for avian and mammalian species following the consumption of treated
vegetation, grain and contaminated insects are likely to be low. The low long-term
risk to insectivorous species and birds grazing on treated grassland is not likely to
arise due to:
(i) the high acute toxicity of fenitrothion to insects, preventing residue build-up in
this food source;

Page 22 of 32
 (ii) the generally low persistence of fenitrothion in the environment; and
(iii) the rapid decline of residues in species forming the diet.
Aquatic organisms (fish and invertebrates) are potentially at risk, especially in the
event of overspray to static water bodies. However buffer zones appropriate to each
crop and monitoring wind direction to prevent spray drift should ensure that aqueous
concentrations remain below the environmentally acceptable concentrations even in
the event of multiple applications. Although fenitrothion is fat-soluble, the rates of
biotransformation and excretion of metabolites largely mitigate bioconcentration.
Label warnings are intended to minimise the risks to fish.
The risks to algal species, earthworms, soil micro-organisms and sewage bacteria
are considered to be low, even in worst-case scenarios, without taking into
consideration the rapid dissipation processes that occur in the environment.
Fenitrothion is extremely toxic to honeybees and highly toxic to non-target
arthropods. However, it does not have growth inhibitory activity and the effects of
treatment are relatively short-lived. Most beneficial insect populations would recover
quite rapidly. Label warnings are intended to minimise the risks to honeybees.
Soil microbiological processes are generally unaffected by use of fenitrothion on
agricultural land.
It is used in agriculture and for public health use.
An acceptable daily intake (ADI) of 0-0.005 mg/kg body weight was established in
2000. The IPCS hazard classification of fenitrothion is: moderately hazardous, class
II.

Formulations and co-formulated active ingredients

The main formulation types available are EC, WP and UL.
Fenitrothion is not co-formulated with other pesticides in UL and WP formulations.
These UL and WP formulations are registered and sold in Saudi Arabia, Sri Lanka,
Thailand, Malaysia, Vietnam, Brazil, Australia, Argentina, Colombia and Venezuela.

Methods of analysis and testing

The previous analytical method for the active ingredient (including identity tests) was
Sumitomo Chemical, 1983, HA-0139. The fenitrothion is determined by GC on a 3%
Polyphenyl ether (7 Rings) / Chromosorb W (HP, 80-100 mesh) column with FID and
with internal standardisation using fluorenthene. The CIPAC method was been
adopted as a GC method on packed column.
A new method for fenitrothion, based on HPLC and external standardisation, is used
by Sumitomo and are the methods referred to in the specifications for fenitrothion
products.
The methods used for the determination of relevant (toxicologically significant)
impurities are:
(i) S-methyl fenitrothion, which is based on normal phase HPLC using a
µBondapak CN column with UV detection at 254 nm.

Page 23 of 32
 (ii) TMPP, which is based on capillary GC using a DB1 column with FID detection
and an internal standard.
Test methods for determination of physico-chemical properties of the technical active
ingredient were OECD and USEPA, while those for the formulations were CIPAC, as
indicated in the specifications.

Physical and chemical properties of formulations

The physical properties, the methods for testing them and the limits proposed for the
EC, WP and UL formulations, comply with the requirements of the FAO/WHO
manual (March 2006 revision of the 1st edition). These results are presented as
determined or calculated values in the supporting documents supplied by Sumitomo
as shown in the reference section.

Containers and packaging

No special requirements for containers and packing have been identified.

Expression of the active ingredient

The active ingredient is expressed as fenitrothion, in g/kg or alternatively for liquid
formulated products, in g/l. In case of dispute, the analytical result is expressed as
g/kg.

Page 24 of 32
 ANNEX 1

HAZARD SUMMARY PROVIDED BY THE PROPOSER

Notes:
(i) The proposer confirmed that the toxicological and ecotoxicological data
included in the summary below were derived from fenitrothion having impurity
profiles similar to those referred to in the table above.
(ii) The conclusions expressed in the summary below are those of the proposer,
unless otherwise specified.

Notes:
Acute toxicity was low in Rats, Rabbits, Guinea Pigs, in both males and females in
general toxicity and neurotoxicity terms, as shown by the LD50, LC50. NOELs and
NOAELs. The Hershberger assay in Rats showed no anti-androgenicity or
androgenicity.
Fenitrothion is unlikely to pose a carcinogenic risk to humans.
Fenitrothion was not genotoxic in a range of studies in vitro and in vivo.

Page 25 of 32
Table A. Toxicology profile of the fenitrothion technical material, based on
acute toxicity, irritation and sensitization
Species Test Purity Guideline, duration, Result Study number
% doses and conditions

Rats, male Acute oral 96.6% Dose levels: 600, 1000, LD50 = 1700 mg/kg bw for HT-0353
& female 1400, 1800, 2200, 2600, male, 1720 mg/kg bw for
3000 mg/kg female
Rats, male Acute dermal 97.2% Dose levels: 310, 625, LD50 = 890 mg/kg bw for HT-0187
& female 1250, 2500, 5000 mg/kg male, 1200 mg/kg bw for
female
Rats, male Acute 96.6% 4 hours whole body LC50 = >2210 mg/m3 for HT-0352
& female inhalation exposure, male, >2210mg/m3 for
Dose levels: 3.91, 8.90, female
38.2, 1010, 2210 mg/m3
Rabbits, Skin irritation 96.5% Dose levels: 0.5 ml Negative HT-0201
male &
female
Rabbits, Eye irritation 96.5% Dose levels: 0.5 ml Unwashed: Minimal HT-0201
male & Washed: Negative
female
Guinea pigs Skin 97.2% Landsteiner-Draize’s Negative HT-0181
sensitization method
Rats Acute 94.3% Dose levels: 12.5, 50, NOAEL: 12.5 mg/kg/day HT-0512
neurotoxicity 200mg/kg for males, for male, not
50, 200, 800mg/kg for demonstrated for female
female

Table B. Toxicology profile of the technical material based on repeated

administration (sub-acute to chronic)
Species Test Purity % Guideline, Result Study number
duration,
doses and
conditions
Rats, Subacute feeding Unknown 6 months NOAEL:10 ppm HT-0538
male & toxicity Dose levels: (0.59 mg/kg/day for males,
female 10, 30, 150 0.64 mg/kg/day for females)
ppm
Rats, Subacute feeding 94.3% 3 months General toxicity NOAEL: HT-0520
male & neurotoxicity Dose levels: 6, 20 ppm
female 20, 60, 200 (1.32 mg/kg/day for males,
ppm 1.56 mg/kg/day for females)
Neurotoxicity NOAEL:
200 ppm (13.8 mg/kg/day) for
males, 60 ppm (4.85
mg/kg/day) for females
Dogs, Subacute feeding 96.8% 1 year NOEL: 10 ppm HT-0374
male & toxicity Dose levels: 5, NOAEL: 50 ppm
female 10, 50 ppm (1.57 mg/kg/day for males,
1.59 mg/kg/day for females)
Rabbits, Subacute dermal 93.7% 21 days NOEL (local): <3 mg/kg/day HT-0488
male & toxicity Dose levels: 3, NOAEL (systemic):
female 10, 50, 250 3 mg/kg/day
mg/kg/day

Page 26 of 32
Species Test Purity % Guideline, Result Study number
duration,
doses and
conditions
Rats, Chronic feeding 97.2% 92 weeks NOEL:5 ppm HT-0001
male & toxicity Dose levels: (0.270 mg/kg/day for males, HT-1001
female 2.5, 5, 10 ppm 0.283 mg/kg/day for females)
NOAEL:10 ppm
(0.487 mg/kg/day for males,
0.598 mg/kg/day for females)
Rats, Chronic feeding 97.0% 2 years NOEL & NOAEL: HT-0006
male & toxicity and Dose levels: 10 ppm (0.5 mg/kg/day) HT-0193
female carcinogenicity 10, 30, 100 Carcinogenicity: HT-0194
ppm not carcinogenic
Rats, 2 generation 94.6% Dose levels: Parental NOAEL: HT-0452
male & reproduction, 10, 40 or 120 10 ppm (0.7 mg/kg/day) HT-0513
female feeding ppm Pup NOAEL: 40 ppm
(2.3-5.4 mg/kg/day)
Reproduction NOAEL: 120
ppm (7.4-15.2 mg/kg/day)
Rats, Teratogenicity 96.6% Dose levels: 3, Maternal NOAEL: HT-0382
male & and 8 or 25 8 mg/kg/day
female embryotoxicity, mg/kg/day Developmental NOAEL: 25
oral mg/kg/day
Teratogenicity: not teratogenic
Rabbits, Teratogenicity 96.6% Dose levels: 3, Maternal NOAEL: HT-0367
male & and 10 or 30 10 mg/kg/day
female embryotoxicity, mg/kg/day Developmental NOAEL: 30
oral mg/kg/day
Teratogenicity: not teratogenic
Rat Hershberger 99.7% Dose levels: No antiandrogenicity HT-0551
assay 0.75, 1.5 or 3 No androgenicity
mg/kg daily for
5 days

Page 27 of 32
Table C. Mutagenicity profile of the technical material based on in vitro and in
vivo tests
Species Test Purity Guideline, duration, Result Study number
% doses and conditions
Salmonella Reverse 98.5% 10, 100, 1000 (with and Negative HT-0142
typhimurium (TA1535, mutation without metabolic
TA1537, TA1538) activation), 10000
Escherichia coli (without metabolic
(W3102) activation) µg/plate or 0,
10, 100, 1000 µg/ml
Salmonella Reverse 96.8% 10, 100, 1000 (for Slightly HT-0259
typhimurium (TA100, mutation technical), 0, 100, 500, mutagenic in
TA100 nit-, TA98, TA98 1000, 2000 (for purified) TA100 strain but
nit-) µg/plate, with and not in TA100 nit-
without S9 mix strain.
Salmonella Reverse 94.7% 100, 200, 500, 1000, Slightly HT-0431
typhimurium (TA100, mutation 2000 or 5000 µg/plate, mutagenic in
TA98, TA1535, with and without S9 mix TA100 strain but
TA1537, TA100NR, not in TA100 NR
TA100 1,8-DNP6) strain.
Escherichia coli
(WP2uvrA)
Bacillus subtilis (H17, Rec-assay 98.5% 10, 100, 1000 or 10000 Negative HT-0142
M45 rec-) µg/disk, without
Escherichia coli (W- metabolic activation
3623 pol A-, uvr A-, rec
A-, wild type)
Salmonella
typhimurium (TA1538
uvrB-, TA1978)
The host: Male ICR Host-mediated 98.5% 100 or 200 mg/kg Negative HT-0142
mouse The indicator assay
organism: Salmonella
typhimurium G46
Chinese hamster ovary In vitro 96.7% 75, 150 or 300 µg/ml Negative HT-0420
cells (CHO-K1) chromosomal (+S9, 2 +14 and 2+22 h)
aberration 0, 3, 10 or 30 µg/ml (-S9,
8, 16 and 24 h)
Chinese hamster lung Mammalian cel 94.7% 10-5, 3x10-5, 10-4 or 3x10-Negative HT-0387
4
cells (V79) gene mutation M, with and without S9
mix
Mouse embryo primary Sister 98.6% 10-5, 5x10-5or 10-4 M Negative HT-0208
cultured cell chromatid
exchange
Male ICR mice In vivo 96.8% 200, 400 or 800 mg/kg Negative HT-0235
chromosomal (6, 24 and 48 h)
aberration
Male Sprague-Dawley In vivo 96.8% 100, 200 or 400 mg/kg Negative HT-0258
rats chromosomal (6, 24 and 48 h)
aberration 20, 40 or 80 mg/kg x 5
(24 h interval, sacrificed
6h after the last dose)
Male ICR mice Micronucleus 96.8% 200, 400, 800 or 1600 Negative HT-0234
test mg/kg (24 h)

Page 28 of 32
Species Test Purity % Guideline, duration, Result Study
doses and conditions number
Male Sprague- In vivo / in vitro 94.3%、 300 mg/kg (3, 12 and 24 Negative HT-0444
Dawley rat unscheduled DNA 94.5% h)
hepatocytes synthesis
Male ICR mice and Dominant lethal 98.5% 20 or 200 mg/kg (mouse) Negative HT-0210
male Sprague- assay and 0, 2, 7 or 20 mg/kg
Dawley rats (rat) daily for 5 days

Table D. Ecotoxicology profile of the technical material

Species Test Purity Guideline, duration, Result Study
% doses and conditions number

Daphnia magna Acute toxicity to 94.5% 0, 0.0020, 0.0043, EC50 (48 hour): HW-0328
(48 hours) aquatic 0.010, 0.020, 0.040, 0.0086 mg/l
invertebrates 0.084, 0.180 and 0.340 NOEC (48 hour):
(Daphnia) mg/l (Measured) < 0.002 mg/l
Rainbow trout Acute toxicity to 94.5% 0, 0.26, 0.44, 0.86, 2.0 LC50 (96 hour): HW-0329
Salmo gairdneri fish and 7.0 mg/l 1.3 mg/l
(96 hours) (Measured) NOEC (96 hour):
0.44 mg/l
Bluegill sunfish Acute toxicity to 94.5% 0, 1.0, 0.38, 0.69, 1.2 LC50 (96 hour): HW-0330
Lepomis fish and 6.4 mg/l 2.5 mg/l
macrochirus (Measured) NOEC (96 hour):
(96 hours) 0.69 mg/l
Selenastrum Effects on algal 94.5% 0, 0.24, 0.61, 0.92, 1.9 EC50 (96 hour): HW-0327
capricornutum growth and 4.8 mg/l 1.3 mg/l
(96 hours) (Measured) NOEC (96 hour):
0.61 mg/l
Honey bee Acute oral to bee 94.6% 0, 0.021, 0.047, 0.10, LD50 (48 hours): HW-0481
0.23 and 0.50 µg 0.20 µg a.s./bee
a.s./bee
Honey bee Acute contact to 94.6% 0, 0.063, 0.13, 0.25, LD50 (48 hours): HW-0481
bee 0.50 and 1.0 µg 0.16 µg a.s./bee
a.s./bee
Mallard duck Acute oral toxicity 94.5% 0, 65, 129, 259, 517 LD50: > 1034 HW-0243
and 1034 mg/kg b.w. mg/kg b.w.
NOEL: 129 mg/kg
b.w.
Bobwhite quail Acute oral toxicity 94.5% 0, 16, 32, 65, 129 and LD50: 23 mg/kg HW-0242
259 mg/kg b.w. b.w.
NOEL: < 16
mg/kg b.w.
Mallard duck Short-term dietary 94.5% 0, 313, 625, 1250, 2500 LC50: 1773 ppm HW-0255
toxicity and 5000 ppm NOEC: < 313
ppm
Bobwhite quail Short-term dietary 94.5% 0, 39, 78, 156, 313 and LC50: 126 ppm HW-0254
toxicity 625 ppm NOEC: 39 ppm

Page 29 of 32
 ANNEX 2

REFERENCES

Author and year or Study title. Study identification number. Report identification number.
study number Company conducting the study.
Sumitomo Chemical FAO/WHO Specifications for Pesticides – Proposers (Sumitomo’s) completed
Co. Ltd, 10/2006 template with (i) Manufacturing Process and batch test details (Confidential)
& (ii) specifications including physico-chemical properties, toxicological
summaries, comments & references (Non-confidential)
Sumitomo Chemical Proposers (Sumitomo’s) specifications - Fenitrothion TC, EC, WP and UL and
Co. Ltd, 03/2007 methods of analysis – March 2007 updated version of October 2006
specifications
Sumitomo Chemical Proposers (Sumitomo’s) specifications - Fenitrothion TC, EC, WP and UL and
Co. Ltd, 04/2009 methods of analysis – April 2009 updated version of march 2007
specifications
CIPAC 1980 CIPAC Handbook 1A - Analysis of Technical and Formulated Pesticides
CIPAC 1985 CIPAC Handbook 1C - Analysis of Technical and Formulated Pesticides
BCPC – Ed C Tomlin The e-Pesticide Manual (Twelfth Edition) Version 2.2
2002-2003 (British Crop Protection Council)
RSC, Roberts, T. et Metabolic Pathway of Agrochemicals Pt 2 Insecticides and Fungicides Pages
al 1999 314-325
Report No. HP-0136 Fenitrothion -Vapour Pressure
Sumitomo Chemical Co., Ltd.
Report No. HP-0140 Fenitrothion: Determination of the physico-chemical properties
Sumitomo Chemical Co., Ltd.
Report No. HP-0133 Determination of boiling point of fenitrothion
Sumitomo Chemical Co., Ltd.
Report No. HP-0137 Solubility of fenitrothion in water
Sumitomo Chemical Co., Ltd.
Report No. HP-0145 Partition coefficient (n-octanol;water – K o/w) of [14C] fenitrothion
Sumitomo Chemical Co., Ltd.
Report No. HM-0094 Hydrolysis of fenitrothion in water as a function of pH at 25°C Sumitomo
Chemical Co., Ltd.
Report No. HM-0093 Photodegradation of fenitrothion in water
Sumitomo Chemical Co., Ltd.
Report No. HT-0353 Acute oral toxicity of Sumithion in rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0187 Acute oral, subcutaneous and dermal toxicities of Sumithion technical in mice
and rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0352 Acute inhalation toxicity of Sumithion in rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0201 Primary eye and skin irritation tests of SumithionR technical in rabbits
Sumitomo Chemical Co., Ltd.
Report No. HT-0181 Skin sensitization test of Sumithion technical in guinea pigs
Sumitomo Chemical Co., Ltd.
Report No. HT-0512 An acute study of the potential effects of orally administered fenitrothion on
behavior and neuromorphology in rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0538 Six month feeding study of Sumithion, Sumioxon and p-nitrocresol in rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0520 A 3-month dietary study of the potential effects of fenitrothion on behavior,
neurochemistry and neuromorphology in rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0374 One year dietary toxicity study in dogs
Sumitomo Chemical Co., Ltd.

Page 30 of 32
Author and year or Study title. Study identification number. Report identification number.
study number Company conducting the study.
Report No. HT-0488 21-day dermal toxicity study in rabbits with Sumithion T.G.
Sumitomo Chemical Co., Ltd.
Report No. HT-0001 Ninety-two week feeding study of Sumithion in rats with special reference to
cholinesterase activity
Sumitomo Chemical Co., Ltd.
Report No. HT-1001 Sumithion: 92-week feeding study: Individual data
Sumitomo Chemical Co., Ltd.
Report No. HT-0006 Two-year dietary administration in the rat
Sumitomo Chemical Co., Ltd.
Report No. HT-0193 104-week chronic administration in rats Project No. 343-107:Individual animal
data Volume I
Sumitomo Chemical Co., Ltd.
Report No. HT-0194 104-week chronic administration in rats Project No. 343-107: Individual
histopathology findings
Sumitomo Chemical Co., Ltd.
Report No. HT-0452 Reproductive effects of Sumithion administered orally in feed to
Crl:CD®(SD)BR rats for two generations
Sumitomo Chemical Co., Ltd.
Report No. HT-0513 Reproductive effects of Sumithion administered orally in feed to
Crl:CD®(SD)BR rats for two generations
Sumitomo Chemical Co., Ltd.
Report No. HT-0382 Teratology study in rats with Sumithion
Sumitomo Chemical Co., Ltd.
Report No. HT-0367 Teratology study in rabbits
Sumitomo Chemical Co., Ltd.
Report No. HT-0551 Evaluation of a 5-day Hershberger assay using young mature male rats:
methyltestosterone and p,p’-DDE, but not fenitrothion, exhibited androgenic
or antiandrogenic activity in vivo.
J. Toxicol. Sci. 25, (5), 403-415
Report No. HT-0142 Studies on mutagenicity of SumithionR with bacterial systems
Sumitomo Chemical Co., Ltd.
Report No. HT-0259 Mutagenicity tests of Sumithion with nitroreductase-defective bacteria
Sumitomo Chemical Co., Ltd.
Hara, M. et al., 1989 Mutagenicity studies on fenitrothion in bacteria and mammalian cells
Mutation Research, 222, 53-61, Report No. HT-0431
Report No. HT-0420 In vitro chromosomal aberration test of Sumithion in Chinese hamster ovary
cells (CHO-K1) in culture
Sumitomo Chemical Co., Ltd.
Report No. HT-0387 In vitro gene mutation test of Sumithion in V79 Chinese hamster cells in
culture
Sumitomo Chemical Co., Ltd.
Report No. HT-0208 Effects of fenitrothion on sister chromatid exchanges (SCE) in cultured
mouse embryo cells
Sumitomo Chemical Co., Ltd.
Report No. HT-0235 In vivo chromosomal aberration test of SumithionR on bone marrow cells of
mice
Sumitomo Chemical Co., Ltd.
Report No. HT-0258 In vivo chromosomal aberration test of SumithionR on bone marrow cells of
rats
Sumitomo Chemical Co., Ltd.
Report No. HT-0234 The micronucleus test of SumithionR
Sumitomo Chemical Co., Ltd.
Report No. HT-0444 In vivo/in vitro unscheduled DNA synthesis (UDS) test of Sumithion in rat
hepatocytes
Sumitomo Chemical Co., Ltd.
Report No. HT-0210 Dominant lethal test of Sumithion in rats and mice
Sumitomo Chemical Co., Ltd.

Page 31 of 32
Author and year or Study title. Study identification number. Report identification number.
study number Company conducting the study.
Report No. HW-0328 Acute toxicity of fenitrothion to Daphnia magna
Sumitomo Chemical Co., Ltd.
Report No. HW-0329 Acute flow-through toxicity of fenitrothion to rainbow trout (Salmo gairdneri)
Sumitomo Chemical Co., Ltd.
Report No. HW-0330 Acute flow-through toxicity of fenitrothion to bluegill sunfish (Lepomis
macrochirus)
Sumitomo Chemical Co., Ltd.
Report No. HW-0327 Acute toxicity of fenitrothion to Selenastrum capricornutum Prinz
Sumitomo Chemical Co., Ltd.
Report No. HW-0481 Fenitrothion -Acute contact and oral toxicity tests with honey bees (Apis
mellifera)
Sumitomo Chemical Co., Ltd.
Report No. HW-0481 Fenitrothion -Acute contact and oral toxicity tests with honey bees (Apis
mellifera)
Sumitomo Chemical Co., Ltd.
Report No. HW-0243 Sumithion technical grade: An acute oral toxicity study with the mallard
Sumitomo Chemical Co., Ltd.
Report No. HW-0242 Sumithion technical grade: An acute oral toxicity study with the bobwhite
Sumitomo Chemical Co., Ltd.
Report No. HW-0255 Sumithion technical grade: A dietary LC50 study with the mallard
Sumitomo Chemical Co., Ltd.
Report No. HW-0254 Sumithion technical grade: A dietary LC50 study with the bobwhite
Sumitomo Chemical Co., Ltd.
Report No. HA-0139 Analysis of the composition of Sumithion technical grade
Sumitomo Chemical Co., Ltd.
APVMA Comparison of Manufacturing Process, Quality control, specifications and
March 2007 batch analyses information for fenitrothion active constituent submitted to
WHO with the information submitted to APVMA (Australian Pesticides and
Veterinary Medicines Authority)
Sumitomo Chemical, Proposers reply to the JMPS evaluation questions on the Fenitrothion data
9/10/2007, revised submission, both the confidential and non-confidential sections, from JMPS
30/04/2008 2007 Closed Meeting
Mikami, N., et. al., Toxicity Study of S-methylfenitrothion
1977
Toia, R.F., et. al., Identification and Toxicological Evaluation of Impurities in Technical
1980 Malathion and Fenthion
Sumitomo Chemical, Method of Analysis of the composition (Fenitrothion content) of Sumithion TC
2008 and formulations by HPLC, Sumitomo Chemical Co., Ltd. Report No.
CIPAC/4602/m
Sumitomo Chemical, CIPAC Collaborative Trial of the analysis of Fenitrothion in TC and
2008 Formulations by HPLC, Sumitomo Chemical Co., Ltd. Report No.
CIPAC/4603/R
Sumitomo Chemical, Method of Analysis of the S-Methyl fenitrothion content of Sumithion TC and
2007 formulations by HPLC, Sumitomo Chemical Co., Ltd. Report No.
CIPAC/4545/m
Sumitomo Chemical, CIPAC Peer Validation of the determination of S–methyl fenitrothion in
2007 Fenitrothion Technical and Formulations by HPLC Sumitomo Chemical Co.,
Ltd. Report No. CIPAC/4547/R
Sumitomo Chemical, Method of analysis of TMPP content of Sumithion TC and formulations by
2009 GC, Sumitomo Chemical Co., Ltd. Report No. CIPAC /4660/m
Sumitomo Chemical, CIPAC Peer Validation of the analysis of TMPP by GC, Sumitomo Chemical
2009 Co., Ltd. Report No. CIPAC/4661/R

Page 32 of 32